(Q51382080)

4 April 2018

title

Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. (English)

1 reference

4 April 2018

1 reference

3

Leif Gjerstad

1 reference

4 April 2018

4

Erik Taubøll

1 reference

4 April 2018

Dag Aurlien

1

1 reference

4 April 2018

Jan Petter Larsen

series ordinal

2

1 reference

4 April 2018

publication date

29 November 2011

1 reference

4 April 2018

published in

Epilepsia

1 reference

4 April 2018

volume

53

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

258-266

1 reference

4 April 2018

QT alterations in psychopharmacology: proven candidates and suspects

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

SUDEP: overview of definitions and review of incidence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

New SCN5A mutation in a SUDEP victim with idiopathic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Lengthening of corrected QT during epileptic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Combined analysis of risk factors for SUDEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Case-control study of SUDEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

A prospective study on sudden unexpected death in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Sudden unexplained death in epilepsy: observations from a large clinical development program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Opinion of Belgian neurologists on antiepileptic drug treatment in 2006: Belgian study on epilepsy treatment (BESET-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Risk factors for sudden unexpected death in epilepsy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Lamotrigine clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Sudden unexpected death in epilepsy: is carbamazepine implicated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Sudden unexpected death in epilepsy: a review of incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Sudden unexpected death in epilepsy: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

The effect of external pH on the delayed rectifying K+ current in cardiac ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2011.03334.X

10.1111/J.1528-1167.2011.03334.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018